Ignite Creation Date:
2024-05-05 @ 11:36 AM
Last Modification Date:
2024-10-26 @ 9:11 AM
Study NCT ID:
NCT00096200
Status:
COMPLETED
Last Update Posted:
2022-02-08
First Post:
2004-11-09
Brief Title:
Sorafenib With or Without Paclitaxel and Carboplatin in Treating Patients With Recurrent Ovarian Cancer Primary Peritoneal Cancer or Fallopian Tube Cancer
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Recurrent Primary Peritoneal Carcinoma |
| Recurrent Fallopian Tube Carcinoma |
| Recurrent Ovarian Carcinoma |
Keywords: